Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Palisade Bio, Inc. (PALI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.7300-0.0200 (-0.73%)
At close: 04:00PM EST
2.7100 -0.02 (-0.73%)
After hours: 07:55PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close2.7500
Open2.7200
Bid2.7100 x 2900
Ask2.7300 x 900
Day's Range2.6365 - 3.0683
52 Week Range1.7400 - 76.5000
Volume1,142,233
Avg. Volume3,664,701
Market Cap10.825M
Beta (5Y Monthly)N/A
PE Ratio (TTM)0.21
EPS (TTM)13.1500
Earnings DateMar 16, 2023 - Mar 20, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PALI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Palisade Bio, Inc.
    Analyst Report: PerkinElmer, Inc.PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious-disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.
    Rating
    Fair Value
    Economic Moat
    2 years agoMorningstar
View more
  • ACCESSWIRE

    JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

    JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2023 Companies to Watch Event, January 17-19, 2023.

  • GlobeNewswire

    Palisade Bio Further Strengthens Balance Sheet with Early Exercise of Warrants Resulting in Cash Proceeds of $4.9 Million

    Proceeds expected to extend cash runway to fund operations into the second half of 2024 Carlsbad, CA, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications (the “Company”), today announced that holders of an additional 1.46 million common stock purchase warrants issued pursuant to the Company’s August 2022 public offering (the “Warrants”) have exercised such War

  • GlobeNewswire

    Palisade Bio to Present at the Virtual Investor 2023 Companies to Watch Event

    Live video webcast on Tuesday, January 17th at 3:00 PM ET Carlsbad, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that J.D. Finley, Interim Chief Executive Officer of Palisade Bio will present at the Virtual Investor 2023 Companies to Watch Event on Tuesday, January 17, 2023 at 3:00 PM ET. A live video webcast of the presentation will be a

Advertisement
Advertisement